Evotec International GmbH and Nosopharm SAS have jointly described odilorhabdin analogues reported to be useful for the treatment of multidrug-resistant bacterial infections.
Despite numerous therapeutic research efforts, treatment of BV remains cumbersome ... or Clindamycin 300 mg orally twice daily for 7 days Bacterial vaginosis (BV) is a condition characterized ...